Back
Progressive Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
63
PGR
Progressive
Last Price:
$262.5800
Seasonality Move:
10.3%
Sell
41
SRPT
Sarepta Therapeutics
Last Price:
$107.93
Seasonality Move:
1.75%
Buy
63
Progressive (PGR)
is a Buy
Is Progressive a Buy, Sell or Hold?
-
The current Progressive [PGR] share price is $262.6000. The Score for PGR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
PGR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PGR Stock Price Chart
What is Progressive's stock price today?
-
The Progressive share price today is $262.6000Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PGR is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $107.95Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
PGR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4 | Buy |
Relative Strength Index (14 RSI): | 70.25 | Buy |
Chaikin Money Flow: | 349807 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (239.6708 - 254.0908) | Buy |
Bollinger Bands (100): | (242.117 - 258.437) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.94 | Sell |
Relative Strength Index (14 RSI): | 33.84 | Sell |
Chaikin Money Flow: | -502758 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (111.52 - 119.16) | Sell |
Bollinger Bands (100): | (114.38 - 127.78) | Sell |
PGR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 254.97 | Buy |
20-day SMA: | 248.64 | Buy |
50-day SMA: | 246.36 | Buy |
200-day SMA: | 235.61 | Buy |
8-day EMA: | 256.16 | Buy |
20-day EMA: | 250.93 | Buy |
50-day EMA: | 248.46 | Buy |
200-day EMA: | 233.42 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 111.57 | Sell |
20-day SMA: | 114.25 | Sell |
50-day SMA: | 119.8 | Sell |
200-day SMA: | 128.55 | Sell |
8-day EMA: | 110.88 | Sell |
20-day EMA: | 113.91 | Sell |
50-day EMA: | 117.81 | Sell |
200-day EMA: | 123.39 | Sell |
Progressive Earnings Growth & PGR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.74 per share, an increase this year of $0.80 per share, and an increase next year of $1.04 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.
Progressive Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |